The technologies listed in this portfolio are currently available for licensing. The list is frequently updated and includes descriptions of technologies related to patents and other intellectual property owned or otherwise managed by Kansas State University. Please contact our commercialization partners for more information about licensing opportunities for any of these technologies.
As new KSU technologies are included in our portfolio, they will be added to the listings below. Entries to the listings also include announcements or press releases of significant KSU Technology events.
Improving the Yield of Influenza Viruses and Vaccines Generated in Cell-Based Systems (11-30)
Advanced 3D Cell Culture Research Tool for Drug Discovery and Development Researchers (11-28)
Chemical Agents, and Their Derivatives for Antifungal Applications (11-16)
Novel Broad-Spectrum Antivirals against Noroviruses, Picornaviruses and Coronaviruses (11-13)
Antenna for GPS, Galileo and GLONASS Systems with Superior Multipath Characteristics (11-09)
Effective, Non-Invasive dsRNA Delivery Method for Insect Control (11-08)
A Novel Fusion Peptide with Potent Anti-Cancer Effects (11-06)
Thermally Stable, Transparent, Pressure Sensitive Adhesives from Plant Oils (11-02)
Red Yeast Fermentation to Produce Natural Astaxanthin and b-carotene Enriched Fish Meal (10-23)
Luciferase Transfected Stem Cells as Light Source for In-Situ Photodynamic Therapy of Cancer (10-21)
Novel Peptides for Therapeutic Treatment of Mesenteric Ischemia & Reperfusion Injury (10-19)

Visit the following links to browse through our available technologies.

Donated technologies are available for license through the Kansas State University Institute for Commercialization (KSU-IC). These are primarily unused corporate technologies that KSU-IC acquired through its patent donation program.